Jiangsu Apon Medical Technology Co Ltd Class A (300753) — Working Capital to Net Assets Ratio
Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a Working Capital to Net Assets ratio of 41.4% as of September 2025. Working capital of CN¥283.71 Million (current assets of CN¥410.77 Million minus current liabilities of CN¥127.06 Million) is measured against net assets of CN¥686.08 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Jiangsu Apon Medical Technology Co Ltd C balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jiangsu Apon Medical Technology Co Ltd Class A Working Capital to Net Assets (2014–2024)
This chart shows how Jiangsu Apon Medical Technology Co Ltd Class A's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 41.4%, reflecting working capital of CN¥283.71 Million against net assets of CN¥686.08 Million CNY. Check 300753 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Jiangsu Apon Medical Technology Co Ltd C worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 47.0% | CN¥332.82 Million | CN¥707.86 Million | CN¥458.44 Million | CN¥125.62 Million | ▲ +2.2 pp |
| 2023 | 44.8% | CN¥312.43 Million | CN¥697.20 Million | CN¥442.30 Million | CN¥129.87 Million | ▲ +1.4 pp |
| 2022 | 43.5% | CN¥298.26 Million | CN¥686.36 Million | CN¥445.38 Million | CN¥147.12 Million | ▼ -8.8 pp |
| 2021 | 52.2% | CN¥407.65 Million | CN¥780.52 Million | CN¥484.21 Million | CN¥76.56 Million | ▼ -7.0 pp |
| 2020 | 59.2% | CN¥438.06 Million | CN¥739.84 Million | CN¥523.30 Million | CN¥85.24 Million | ▼ -8.8 pp |
| 2019 | 68.0% | CN¥459.21 Million | CN¥674.88 Million | CN¥539.48 Million | CN¥80.27 Million | ▼ -4.7 pp |
| 2018 | 72.7% | CN¥445.95 Million | CN¥613.39 Million | CN¥517.88 Million | CN¥71.94 Million | ▲ +7.8 pp |
| 2017 | 64.9% | CN¥181.29 Million | CN¥279.38 Million | CN¥234.44 Million | CN¥53.15 Million | ▲ +5.6 pp |
| 2016 | 59.3% | CN¥136.21 Million | CN¥229.59 Million | CN¥201.13 Million | CN¥64.92 Million | ▼ -4.7 pp |
| 2015 | 64.1% | CN¥93.15 Million | CN¥145.40 Million | CN¥128.03 Million | CN¥34.88 Million | ▲ +6.3 pp |
| 2014 | 57.8% | CN¥47.02 Million | CN¥81.37 Million | CN¥81.45 Million | CN¥34.43 Million | — |